Cargando…
Persistent endotheliopathy in the pathogenesis of long COVID syndrome
BACKGROUND: Persistent symptoms including breathlessness, fatigue, and decreased exercise tolerance have been reported in patients after acute SARS‐CoV‐2 infection. The biological mechanisms underlying this “long COVID” syndrome remain unknown. However, autopsy studies have highlighted the key roles...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420256/ https://www.ncbi.nlm.nih.gov/pubmed/34375505 http://dx.doi.org/10.1111/jth.15490 |
_version_ | 1783748901505859584 |
---|---|
author | Fogarty, Helen Townsend, Liam Morrin, Hannah Ahmad, Azaz Comerford, Claire Karampini, Ellie Englert, Hanna Byrne, Mary Bergin, Colm O’Sullivan, Jamie M. Martin‐Loeches, Ignacio Nadarajan, Parthiban Bannan, Ciaran Mallon, Patrick W. Curley, Gerard F. Preston, Roger J.S. Rehill, Aisling M. McGonagle, Dennis Ni Cheallaigh, Cliona Baker, Ross I. Renné, Thomas Ward, Soracha E. O’Donnell, James S. O’Connell, Niamh Ryan, Kevin Kenny, Dermot Fazavana, Judicael |
author_facet | Fogarty, Helen Townsend, Liam Morrin, Hannah Ahmad, Azaz Comerford, Claire Karampini, Ellie Englert, Hanna Byrne, Mary Bergin, Colm O’Sullivan, Jamie M. Martin‐Loeches, Ignacio Nadarajan, Parthiban Bannan, Ciaran Mallon, Patrick W. Curley, Gerard F. Preston, Roger J.S. Rehill, Aisling M. McGonagle, Dennis Ni Cheallaigh, Cliona Baker, Ross I. Renné, Thomas Ward, Soracha E. O’Donnell, James S. O’Connell, Niamh Ryan, Kevin Kenny, Dermot Fazavana, Judicael |
author_sort | Fogarty, Helen |
collection | PubMed |
description | BACKGROUND: Persistent symptoms including breathlessness, fatigue, and decreased exercise tolerance have been reported in patients after acute SARS‐CoV‐2 infection. The biological mechanisms underlying this “long COVID” syndrome remain unknown. However, autopsy studies have highlighted the key roles played by pulmonary endotheliopathy and microvascular immunothrombosis in acute COVID‐19. OBJECTIVES: To assess whether endothelial cell activation may be sustained in convalescent COVID‐19 patients and contribute to long COVID pathogenesis. PATIENTS AND METHODS: Fifty patients were reviewed at a median of 68 days following SARS‐CoV‐2 infection. In addition to clinical workup, acute phase markers, endothelial cell (EC) activation and NETosis parameters and thrombin generation were assessed. RESULTS: Thrombin generation assays revealed significantly shorter lag times (p < .0001, 95% CI −2.57 to −1.02 min), increased endogenous thrombin potential (p = .04, 95% CI 15–416 nM/min), and peak thrombin (p < .0001, 95% CI 39–93 nM) in convalescent COVID‐19 patients. These prothrombotic changes were independent of ongoing acute phase response or active NETosis. Importantly, EC biomarkers including von Willebrand factor antigen (VWF:Ag), VWF propeptide (VWFpp), and factor VIII were significantly elevated in convalescent COVID‐19 compared with controls (p = .004, 95% CI 0.09–0.57 IU/ml; p = .009, 95% CI 0.06–0.5 IU/ml; p = .04, 95% CI 0.03–0.44 IU/ml, respectively). In addition, plasma soluble thrombomodulin levels were significantly elevated in convalescent COVID‐19 (p = .02, 95% CI 0.01–2.7 ng/ml). Sustained endotheliopathy was more frequent in older, comorbid patients, and those requiring hospitalization. Finally, both plasma VWF:Ag and VWFpp levels correlated inversely with 6‐min walk tests. CONCLUSIONS: Collectively, our findings demonstrate that sustained endotheliopathy is common in convalescent COVID‐19 and raise the intriguing possibility that this may contribute to long COVID pathogenesis. |
format | Online Article Text |
id | pubmed-8420256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis |
record_format | MEDLINE/PubMed |
spelling | pubmed-84202562021-09-07 Persistent endotheliopathy in the pathogenesis of long COVID syndrome Fogarty, Helen Townsend, Liam Morrin, Hannah Ahmad, Azaz Comerford, Claire Karampini, Ellie Englert, Hanna Byrne, Mary Bergin, Colm O’Sullivan, Jamie M. Martin‐Loeches, Ignacio Nadarajan, Parthiban Bannan, Ciaran Mallon, Patrick W. Curley, Gerard F. Preston, Roger J.S. Rehill, Aisling M. McGonagle, Dennis Ni Cheallaigh, Cliona Baker, Ross I. Renné, Thomas Ward, Soracha E. O’Donnell, James S. O’Connell, Niamh Ryan, Kevin Kenny, Dermot Fazavana, Judicael J Thromb Haemost Brief Report BACKGROUND: Persistent symptoms including breathlessness, fatigue, and decreased exercise tolerance have been reported in patients after acute SARS‐CoV‐2 infection. The biological mechanisms underlying this “long COVID” syndrome remain unknown. However, autopsy studies have highlighted the key roles played by pulmonary endotheliopathy and microvascular immunothrombosis in acute COVID‐19. OBJECTIVES: To assess whether endothelial cell activation may be sustained in convalescent COVID‐19 patients and contribute to long COVID pathogenesis. PATIENTS AND METHODS: Fifty patients were reviewed at a median of 68 days following SARS‐CoV‐2 infection. In addition to clinical workup, acute phase markers, endothelial cell (EC) activation and NETosis parameters and thrombin generation were assessed. RESULTS: Thrombin generation assays revealed significantly shorter lag times (p < .0001, 95% CI −2.57 to −1.02 min), increased endogenous thrombin potential (p = .04, 95% CI 15–416 nM/min), and peak thrombin (p < .0001, 95% CI 39–93 nM) in convalescent COVID‐19 patients. These prothrombotic changes were independent of ongoing acute phase response or active NETosis. Importantly, EC biomarkers including von Willebrand factor antigen (VWF:Ag), VWF propeptide (VWFpp), and factor VIII were significantly elevated in convalescent COVID‐19 compared with controls (p = .004, 95% CI 0.09–0.57 IU/ml; p = .009, 95% CI 0.06–0.5 IU/ml; p = .04, 95% CI 0.03–0.44 IU/ml, respectively). In addition, plasma soluble thrombomodulin levels were significantly elevated in convalescent COVID‐19 (p = .02, 95% CI 0.01–2.7 ng/ml). Sustained endotheliopathy was more frequent in older, comorbid patients, and those requiring hospitalization. Finally, both plasma VWF:Ag and VWFpp levels correlated inversely with 6‐min walk tests. CONCLUSIONS: Collectively, our findings demonstrate that sustained endotheliopathy is common in convalescent COVID‐19 and raise the intriguing possibility that this may contribute to long COVID pathogenesis. The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis 2021-10 2022-12-21 /pmc/articles/PMC8420256/ /pubmed/34375505 http://dx.doi.org/10.1111/jth.15490 Text en © 2021 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Brief Report Fogarty, Helen Townsend, Liam Morrin, Hannah Ahmad, Azaz Comerford, Claire Karampini, Ellie Englert, Hanna Byrne, Mary Bergin, Colm O’Sullivan, Jamie M. Martin‐Loeches, Ignacio Nadarajan, Parthiban Bannan, Ciaran Mallon, Patrick W. Curley, Gerard F. Preston, Roger J.S. Rehill, Aisling M. McGonagle, Dennis Ni Cheallaigh, Cliona Baker, Ross I. Renné, Thomas Ward, Soracha E. O’Donnell, James S. O’Connell, Niamh Ryan, Kevin Kenny, Dermot Fazavana, Judicael Persistent endotheliopathy in the pathogenesis of long COVID syndrome |
title | Persistent endotheliopathy in the pathogenesis of long COVID syndrome |
title_full | Persistent endotheliopathy in the pathogenesis of long COVID syndrome |
title_fullStr | Persistent endotheliopathy in the pathogenesis of long COVID syndrome |
title_full_unstemmed | Persistent endotheliopathy in the pathogenesis of long COVID syndrome |
title_short | Persistent endotheliopathy in the pathogenesis of long COVID syndrome |
title_sort | persistent endotheliopathy in the pathogenesis of long covid syndrome |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420256/ https://www.ncbi.nlm.nih.gov/pubmed/34375505 http://dx.doi.org/10.1111/jth.15490 |
work_keys_str_mv | AT fogartyhelen persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT townsendliam persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT morrinhannah persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT ahmadazaz persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT comerfordclaire persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT karampiniellie persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT englerthanna persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT byrnemary persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT bergincolm persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT osullivanjamiem persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT martinloechesignacio persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT nadarajanparthiban persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT bannanciaran persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT mallonpatrickw persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT curleygerardf persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT prestonrogerjs persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT rehillaislingm persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT mcgonagledennis persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT nicheallaighcliona persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT bakerrossi persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT rennethomas persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT wardsorachae persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT odonnelljamess persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT oconnellniamh persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT ryankevin persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT kennydermot persistentendotheliopathyinthepathogenesisoflongcovidsyndrome AT fazavanajudicael persistentendotheliopathyinthepathogenesisoflongcovidsyndrome |